Barclays Wealth and Investment Management related stories
All articles and analysis
- Biohaven Pharmaceutical files to go public
New Haven, Connecticut-based Biohaven Pharmaceutical Holding Company, a clinical-stage biopharmaceutical company targeting neurological diseases, has filed for an $100 million IPO, according to an SEC filing https://www.sec.gov/Archives/edgar/data/1689813/000104746917002426/a2231694zs-1.htm Biohaven has applied to list the stock on the New York Stock Exchange under the ticker symbol "BHVN." Morgan Stanley, Piper Jaffray and Barclays are the lead underwriters. Biohaven's shareholders include Portage Biotech Inc, Vivo Capital and RA Capital.
- Bain, Cinven pay up to win backing for Stada deal: Reuters
Buyout groups Bain Capital and Cinven won an auction for German drugmaker Stada (STAGn.DE) on Monday after a surprisingly large increase on a previous bid valued the company at about 5.3 billion euros ($5.6 billion), Reuters reported.
- LionBird Ventures leads $2.25 mln round for Remesh
Remesh, a software platform that uses AI, machine learning and natural language processing for market research, has raised $2.25 million in seed funding. LionBird Ventures led the round.
- Apax to buy Syneron Candela for $11 per share
Apax Partners has agreed to acquire Syneron Candela, an aesthetic device company, for $11 per share or about $397 million. Barclays is serving as exclusive financial adviser to Syneron Candela while J.P. Morgan is serving as financial adviser to Apax Partners.
Venture-backed Zymeworks files for Canadian and U.S. IPOVancouver-based biotherapeutics company Zymeworks Inc has filed with Canadian and U.S. regulatory authorities for an initial public offering of its common shares. The IPO, which will give the company a listing on the New York Stock Exchange and the Toronto Stock Exchange under the ticker symbol “ZYME”, has not been officially priced; however, the U.S. Securities and Exchange Commission notes a proposed offering size of as much as $100 million (US$75 million). Last year, Zymeworks closed one of Canada's largest venture capital rounds, raising about $87 million (US$61.5 million) /canada/2016/1/zymeworks-scores-61-5-mln-series-a/ It was led by BDC Capital and Lumira Capital and joined by multiple other investors.
Victor Li acquires Alinda's Reliance Home Comfort for $2.8 bln: ReutersVictor Li, co-chairman of Husky Energy Inc and son of one of Asia's richest men, has agreed to acquire Reliance Home Comfort LP, a Canadian provider of heating and cooling systems, from U.S. private investment firm Alinda Capital Partners for $2.8 billion, Reuters reported. Li is the heir to Hong Kong billionaire and property tycoon Li Ka-shing. Several U.S. private equity firms also looked at the asset, sources said. Reliance entered Alinda’s portfolio in 2007, when the investor acquired UE Waterheater Income Fund for about $1.74 billion.
- New Mountain to acquire TRC Companies
New Mountain Capital has agreed to acquire TRC Companies for $17.55 per share. Houlihan Lokey Capital Inc is providing financial advice to TRC on the deal while Covington & Burling LLP is providing legal advice. Also, Barclays is serving as M&A adviser to New Mountain and Kirkland & Ellis LLP is providing legal advice. The deal is expected to close before June 30, 2017. Based in Lowell, Massachusetts, TRC Companies is an engineering, environmental consulting and construction management firm that provides services to the power, environmental, infrastructure and oil and gas markets.
PE HUB First ReadFirst Read starts the day with news that Wells Fargo has reached a $110 million over the fake accounts scandal, Ivanka Trump will become an unpaid federal employee, and Lyft is testing shuttle service in San Francisco and Chicago.
- Sealed Air to sell Diversey Care, other units, to Bain Capital in $3.2 bln deal
Sealed Air Corp said March 27 that it agreed to sell its Diversey Care division and the food hygiene and cleaning business within its Food Care division to Bain Capital Private Equity. The deal is valued at about $3.2 billion. The combined company, called New Diversey, will be a hygiene and cleaning solutions company that will employ approximately 8,600 people globally.
Bain Capital's Canada Goose wraps up IPO, raises $390 mlnCanada Goose Holdings Inc (TSX, NYSE: GOOS), a portfolio company of Bain Capital, has closed its initial public offering in Canada and the United States. Canada Goose raised about $390 million in gross proceeds, which includes the full exercise of an over-allotment purchase option granted to underwriters. Announced earlier this year /canada/2017/3/3439704/ the IPO included a secondary sale by Bain. With its close, the U.S. private equity firm remains the company's majority shareholder. Toronto-based Canada Goose is a designer and maker of luxury outdoor apparel. The public sale reportedly valued it /canada/2017/3/canada-gooses-shares-jump-40-pct-in-stock-market-debut-reuters/ at about $1.8 billion.